Used in research to inhibit PI3Kβ (phosphoinositide 3-kinase beta), particularly in studies related to cancer and cellular signaling pathways. It helps scientists understand tumor growth mechanisms and evaluate potential therapeutic strategies in cancers where PI3K signaling is dysregulated. Also applied in studies exploring platelet function and thrombosis due to PI3Kβ's role in platelet activation. Not used clinically; primarily a tool compound in preclinical research.